.svg){kind=small}
Oct-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Is this your brand?
See your full sales and distribution data: where you sell, how you're priced, and how you rank against the brands next to you on the shelf.
See your brand's dataCarry this brand in your store?
Headset Retailer is free. Connect your POS and see what's selling and what's sitting.
Sign up freeWhere to Buy
Bison Botanics is stocked at 63 licensed dispensaries across New York, with the deepest coverage in Buffalo, Depew, New York, Syracuse, and Ballston Spa. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In October 2026, Bison Botanics concentrated 45.03% of sales in Flower with year-over-year growth of 46.04% but month-over-month decline of 3.33%, while Vapor Pens held 30.09% share with 16.03% YoY growth and a 9.25% MoM drop; together they represented 75.12% of the mix at an average brand price up 9.08% YoY. Pre-Roll contracted to 15.96% share with a 29.50% YoY decline and flat MoM at -0.01%, whereas Beverage remained small at 4.77% share with a 49.15% YoY decline but a 24.72% MoM rebound; this bifurcation indicates the brand’s YoY sales lift of 7.77% is being carried by core inhalables despite short-term pressure from price-sensitive segments. With Concentrates at 2.68% share and a 2.99% MoM dip (no YoY reading), and micro-categories like Tincture & Sublingual at 1.01% share with 45.57% MoM growth and Edible at 0.24% share with 39.39% MoM growth but an 89.89% YoY drop, the mix tilts toward higher-ticket inhalables as the brand’s average item price of $25.48 rises, implying a value ladder where premiumized inhalables offset chronic erosion in auxiliary formats.
Positionally, anchoring 45.03% of volume in Flower while holding rank 88 in Flower in New York suggests a long-tail placement where a 46.04% YoY Flower gain must translate into rank improvement to matter, especially given a 3.33% MoM pullback. The simultaneous 9.25% MoM decline in Vapor Pens at 30.09% share and the 24.72% MoM bounce in Beverage at 4.77% share point to substitution dynamics that can swing monthly share by several points, implying Bison Botanics should defend inhalable basket share while selectively nurturing Beverage/Tincture trial to hedge against Pre-Roll’s 29.50% YoY contraction and Topical’s 70.70% YoY decline. The pattern of modest overall YoY growth at 7.77% against a 26.65% two-year decline, combined with rising average prices and MoM volatility across three minor categories (39.39% for Edible, 45.57% for Tincture & Sublingual, and 14.09% for Topical), implies a repositioning opportunity: keep Flower as the demand anchor while calibrating price-pack architecture in Vapor Pens to stabilize monthly share and using targeted promotions to convert episodic spikes in smaller formats into durable repeat.
Competitive Landscape
Bison Botanics sits at rank #88 in NY Flower for October 2026, improving 19 positions from #107 year over year, but slipping 8 spots from #96 in July 2026 while still far from its #29 peak in December 2024; in contrast, Leal edged up from #2 to #1 and Find. advanced from #5 to #2 as RYTHM moved from #7 to #3, indicating that competitors’ upward mobility is outpacing Bison Botanics’ recovery trajectory despite a double-digit YoY rank gain, which implies the brand is stabilizing but not yet regaining prior relevance within the top quartile.
Notable Products
Bison Botanics leaned on recent launches in October 2026, with new products contributing 23.4% of brand sales and 2 of them, including White Widow (3.5g), landing in the top set. That level of newness alongside a 55.0% share from the top 10 indicates a lineup where a meaningful slice of revenue comes from freshly introduced items, so a large share of sales comes from new products.
Peer avg: average price of the same product type and package size in the same states that month.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
